For the latest
cancer COVID-19 resources, click on this link
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Brain & nervous system
Sign up for latest coverage
Submit your event
cancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Prevention & screening
Middle East and North Africa
Central America and the Caribbean
Australia and Oceania
14 - 18 Apr 2018
McCormick Place North/South, Chicago, United States of America
AACR 2018: Researchers identify epigenetic changes that may help explain racial disparities in breas...
AACR 2018: Sedentary lifestyle drastically increases risk of dying from cancer
AACR 2018: Prototype assays suggest highly specific blood test to screen for cancer is feasible
AACR 2018: A patient-researcher collaboration targeting ROS1 cancer
AACR 2018: For aggressive breast cancer in the brain, researchers clarify immune response
AACR 2018: Cancer cells actively fuel growth and metastasis by reprogramming healthy cells
AACR 2018: Short-acting calcium channel blockers associated with increased risk of pancreatic cancer...
AACR 2018: Dual inhibition of IDO1 and PD-L1 safe in patients with advanced solid tumours
AACR 2018: TLR9 agonist CMP-001 / pembrolizumab combination shows early efficacy in patients with me...
AACR 2018: Updated data for durvalumab plus tremelimumab for NSNSCLC
AACR 2018: Possible biomarker of aggressive breast cancer discovered
AACR 2018: Combination therapy strengthens T cells in melanoma pre-clinical study
AACR 2018: Strategies identified to reverse obesity’s lingering, pro-cancer effects
AACR 2018: Tumours' drug resistance measured up to 10 times faster
AACR 2018: When prostate cancer reaches bone, bone cells may drive overall growth of the disease
AACR 2018: How do melanoma cells survive drug treatment long enough to acquire drug resistance?
AACR 2018: Taking away TIM3 and Tregs stops cancer regrowth after immunotherapy
AACR 2018: Effect of prostate cancer gene can go either way
AACR 2018: An off-the-shelf, dual-targeted CAR T-cell product showed promising results in preclinica...
AACR 2018: Neoadjuvant nivolumab was safe, yielded pathologic responses in patients with resectable ...
AACR 2018: CheckMate-227 meets co-primary endpoint of PFS in NSCLC
AACR 2018: Precancerous colon polyps in patients with Lynch syndrome exhibit immune activation
AACR 2018: Boosting T cell “memory” may result in longer-lasting and effective responses for patient...
AACR 2018: Updated OS data for olaparib in gBRCA-Mutated HER2 negative metastatic breast cancer
AACR 2018: New liquid biopsy-based cancer model reveals data on deadly lung cancer
AACR 2018: First-in-human clinical trial of new targeted therapy drug reports promising responses fo...
AACR 2018: To starve pancreatic tumours, researchers seek to block 'self-eating,' other fuel sources
AACR 2018: Crizotinib yielded a high objective response rate for adult patients with ALK-positive in...
AACR 2018: Selective inhibitor shows early promise in patients with RET-altered cancers
AACR 2018: Pembrolizumab reduced the risk for recurrence of stage 3 melanoma
AACR 2018: Children with non-chromosomal birth defects face higher risk of several childhood cancers
AACR 2018: Acquired HER2 mutations confer resistance to hormone therapy in ER positive MBC
AACR 2018: Vulnerable populations and the health care providers that serve them lack information abo...
AACR 2018: Prior chemotherapies may impair ability to develop effective CAR T cells
AACR 2018: Chlamydia infection is associated with increased risk of ovarian cancer